Program Overview
This online activity features slides and a transcription of the speakers’ presentations from a live meeting held on October 30, 2017. Internationally renowned experts discuss the clinical issues and recent data regarding antiplatelet/anticoagulation in patients with coronary artery disease (CAD). This activity evaluates the data, clinical implications, and recommendations in secondary prevention of CAD, where an anticoagulation management strategy has increasingly shown benefits to patients by providing clot formation and embolization protection with NOACs with acceptable bleeding risks.
Educational Objectives
After completing this activity, the participant should be better able to:
· Describe the rationale for combining an anticoagulant with antiplatelet therapy after stenting
· Relate the clinical implications of anticoagulation in CAD, based on recent data
· Utilize NOACs at the proper dose for patients with moderate or high risk of stroke, advising patients of the risks and benefits, and performing proper follow-up
· Apply guideline recommendations for secondary prevention of CAD after ACS or PCI and discuss the proposed changes that have been recommended based on recent data
Method of Participation and Request for Credit
· There are no fees for participating and receiving CME credit for this activity. During the period December 13, 2017 through December 13, 2018, participants must read the learning objectives and faculty disclosures and study the educational activity.
· If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID #13076. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
· If you have any questions regarding the CME certification of this activity, please contact Postgraduate Institute for Medicine at: information@pimed.com or (303) 799-1930.